Showing results (131-140 of 168) with videos related to

Sort By:
Pageof 17
Pathology Oncology Research : POR|July 18, 2020
Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG FusionsChristian Bernreuther, Ferdous Daghigh, Katharina Möller, et al.
Molecular Cancer Research : MCR|March 28, 2023
BLEACH&STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1-driven Immune Phenotypes with Distinct Spatial OrchestrationElena Bady, Katharina Möller, Tim Mandelkow, et al.
Acta Oncologica (Stockholm, Sweden)|December 2, 2025
L1CAM/CD171 expression in human tumors and its association with tumor phenotypeSeyma Büyücek, Magalie Lurati, Katharina Möller, et al.
Molecular Medicine (Cambridge, Mass.)|June 29, 2026
Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor typesNatalia Gorbokon, Katharina Teljuk, Nina Schraps, et al.
The American Journal of Surgical Pathology|December 10, 2021
Carboxypeptidase A1 (CPA1) Immunohistochemistry Is Highly Sensitive and Specific for Acinar Cell Carcinoma (ACC) of the PancreasRia Uhlig, Hendrina Contreras, Sören Weidemann, et al.
Pathology International|April 14, 2023
Pattern of MUC6 expression across 119 different tumor types: A tissue microarray study on 15 412 tumorsSebastian Dwertmann Rico, Sebastian J A Schliesser, Natalia Gorbokon, et al.
Experimental and Molecular Pathology|November 26, 2025
Prevalence and clinical significance of CBP deficiency and disturbed CBP expression in human cancerVictoria Chirico, Tabea Lenkeit, Seyma Büyücek, et al.
Cellular Oncology (Dordrecht, Netherlands)|March 7, 2020
Prevalence of CD8+ cytotoxic lymphocytes in human neoplasmsNiclas C Blessin, Patrick Spriestersbach, Wenchao Li, et al.
Biomedicines|July 29, 2025
Glucocorticoid Receptor (GR) Expression in Human Tumors: A Tissue Microarray Study on More than 14,000 TumorsMaria Christina Tsourlakis, Simon Kind, Sebastian Dwertmann Rico, et al.
BMC Cancer|December 6, 2018
Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphomaWenchao Li, Niclas C Blessin, Ronald Simon, et al.
Pageof 17